Kane Biotech Announces New Private Placement Offering
Source ↗
👁 0
💬 0
Not for distribution to U.S. news wire services or dissemination in the United States
WINNIPEG, Manitoba, May 07, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces its intention to undertake a non-brokered private placement offering (the “Offering”) of up to 20,000,000 units of the Company (“Units”) at a price of $0.05 per Unit for gross proceeds of up to $1,000,000. Each Unit shall be comprised of one common share of the Comp
WINNIPEG, Manitoba, May 07, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces its intention to undertake a non-brokered private placement offering (the “Offering”) of up to 20,000,000 units of the Company (“Units”) at a price of $0.05 per Unit for gross proceeds of up to $1,000,000. Each Unit shall be comprised of one common share of the Comp
Comments (0)